State Street Corp Greenwich Life Sciences, Inc. Put Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GLSI
# of Institutions
35Shares Held
1.01MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$4.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA268KShares$3.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$1.84 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.25 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny36.9KShares$530,9910.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $185M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...